Browsed by
Tag: Europe

The US and Europe face rising Covid-19 case numbers as they squander lessons from Asia-Pacific

The US and Europe face rising Covid-19 case numbers as they squander lessons from Asia-Pacific

While the Asia-Pacific region treads water until a coronavirus vaccine is found, the West’s biggest economies are drowning as a second wave firmly establishes itself in Europe.



a group of people standing in front of a crowd: Mandatory Credit: Photo by Top Photo Corporation/Shutterstock (10739563a) Eric Chou performs in concert and invited Ella to be his special guest. Eric Chou in concert, Taipei, Taiwan, China - 09 Aug 2020


© Top Photo Corporation/Shutterstock
Mandatory Credit: Photo by Top Photo Corporation/Shutterstock (10739563a) Eric Chou performs in concert and invited Ella to be his special guest. Eric Chou in concert, Taipei, Taiwan, China – 09 Aug 2020

Europe is now reporting more daily infections than the United States, Brazil, or India — the countries that have been driving the global case count for months — as public apathy grows towards coronavirus guidelines. Several countries are seeing infection rates spiral again after a summer lull that saw measures to contain the virus and travel restrictions relaxed.



a man wearing a suit and tie: US President Donald Trump removes his mask on his return to the White House from Walter Reed National Military Medical Center, where he was treated for coronavirus.


© Win McNamee/Getty Images North America/Getty Images
US President Donald Trump removes his mask on his return to the White House from Walter Reed National Military Medical Center, where he was treated for coronavirus.

In the United Kingdom, for example, questions are being asked about whether Prime Minister Boris Johnson’s decision to lift the country’s lockdown in June was premature. Northern England’s current high rates of Covid-19 are down to the fact that infections “never dropped as far in the summer as they did in the south,” Jonathan Van-Tam, Britain’s deputy chief medical officer, told a press conference on Monday.



a large crowd of people: Thousands of revelers gathered at an open air water park in the Chinese city of Wuhan, ground zero of the pandemic, for an electronic music festival in August.


© STR/AFP/AFP via Getty Images
Thousands of revelers gathered at an open air water park in the Chinese city of Wuhan, ground zero of the pandemic, for an electronic music festival in August.

It is just the latest problem to beset Britain’s slapdash pandemic response. There are now more patients in hospital with Covid-19 in England than there were in March, when a nationwide lockdown was imposed, according to Johnson and health officials.

France and the Netherlands broke

Read the rest
Electric cars to triple market share in Europe amid COVID-19, researchers say

Electric cars to triple market share in Europe amid COVID-19, researchers say

By Kate Abnett



text: A battery charger sign for electric cars is painted on the ground of a parking ground near the soccer stadium in Wolfsburg


© Reuters/Kai Pfaffenbach
A battery charger sign for electric cars is painted on the ground of a parking ground near the soccer stadium in Wolfsburg

BRUSSELS (Reuters) – Electric vehicles made up 8% of car sales in Europe in the first half of 2020, putting them on track to triple their market share this year, according to analysis by the NGO Transport & Environment (T&E).

Loading...

Load Error

While the novel coronavirus pandemic has seen overall car sales plummet, sales of electric cars – which T&E defined as both battery and plug-in hybrid models – have increased.

This saw electric cars more than triple their market share in the European Economic Area (EEA), compared with the first half of last year, T&E said.

Outright sales of such vehicles are expected to roughly double this year, to one million units, it said.

T&E attributed the sales increase to tougher European Union car emissions standards, which took effect this year, and post-pandemic purchase incentives in Germany and France.

The NGO expects carmakers to meet the 2020 emissions standards, which would see electric and plug-in hybrid vehicles triple their market share in 2020 to 10% of EEA car sales.

“It is because of the EU emissions standards, but it is also thanks to many investments carmakers made last year,” report co-author Julia Poliscanova said.

The European Automobile Manufacturers’ Association (ACEA) said electric vehicle sales have been boosted by national support schemes to foster economic recovery from the COVID-19 pandemic but that this trend was not necessarily a long-term one.

“It is difficult to make any predictions on future long-term shifts in consumer behaviour from such ‘artificial’ growth driven by subsidies,” ACEA said.

T&E urged the EU to set tougher future emissions targets to ensure electric vehicles keep edging out polluting models.

Read the rest
CNS Pharmaceuticals begins manufacturing Berubicin in Europe (NASDAQ:CNSP)

CNS Pharmaceuticals begins manufacturing Berubicin in Europe (NASDAQ:CNSP)

CNS Pharmaceuticals’ (NASDAQ:CNSP) European manufacturer, BSP Pharmaceuticals has begun the manufacturing process for Berubicin drug product.

The drug is a lead candidate for the treatment of glioblastoma multiforme or GBM, an aggressive form of brain cancer currently considered incurable.

The company’s focus remains on initiating a U.S. Phase 2 trial for Berubicin in Q1 of 2021.

“With the manufacturing of our Berubicin Drug Product in Europe, we continue to advance closer toward an IND filing for Berubicin, which we expect to submit later this quarter.” says John Climaco, CEO.

Press Release

Source Article Read the rest

CNS Pharmaceuticals Begins Manufacturing of Berubicin in Europe

CNS Pharmaceuticals Begins Manufacturing of Berubicin in Europe

HOUSTON, Oct. 9, 2020 /PRNewswire/ — CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that the Company’s European manufacturer, BSP Pharmaceuticals S.p.A. (“BSP”), has begun the manufacturing process for Berubicin Drug Product, its lead drug candidate for the treatment of glioblastoma multiforme (GBM), an aggressive form of brain cancer currently considered incurable.

(PRNewsfoto/CNS Pharmaceuticals, Inc.)

“Our preparations for filing an IND for Berubicin require continued execution in both our clinical and manufacturing initiatives,” stated John Climaco, CEO of CNS Pharmaceuticals. “With the manufacturing of our Berubicin Drug Product in Europe, we continue to advance closer toward an IND filing for Berubicin, which we expect to submit later this quarter.  We have also made significant progress on the clinical front and recently engaged Worldwide Clinical Trials as the contract research organization, Image Analysis Group (“IAG”) as the imaging partner, and Berry Consultants as a biostatistical advisor for our Phase 2 trial design. We have also added Dr. Patrick Wen, a renowned neuro-oncologist, to our Scientific Advisory Board. Our laser focus remains on initiating a U.S. Phase 2 trial for Berubicin in Q1 of 2021 and we continue to demonstrate our ability to execute our operational and clinical plans toward that goal.”

As part of the Company’s plan to mitigate COVID-19-related delay risks, diversify its supply chain and provide for localized availability of Berubicin, the Company implemented a dual-track drug product manufacturing strategy. Under this dual-track strategy, it engaged two separate manufacturers for Berubicin on different continents, both U.S.-based Pharmaceutics International, Inc. (“Pii”) and Italy-based BSP. As previously announced, CNS completed synthesis of Berubicin active pharmaceutical ingredient (API) and shipped API to both Pii and

Read the rest
In Europe, Hopes for an Economic Recovery Are Fading: Live Updates

In Europe, Hopes for an Economic Recovery Are Fading: Live Updates

Credit…Albert Gea/Reuters

What hopes remained that Europe was recovering from the economic catastrophe delivered by the pandemic have all but disappeared as the lethal virus has resumed spreading rapidly.

France, Europe’s second-largest economy, this week amplified the concern as the government downgraded its forecast pace of expansion for the last three months of the year from an already minimal 1 percent to zero. Overall, the statistics agency predicts the economy will contract by 9 percent this year.

The diminished expectations are a direct outgrowth of alarm over the revival of the virus. France reported nearly 19,000 new cases on Wednesday — a one-day record, and nearly double the number seen the day before. The surge prompted President Emmanuel Macron to announce new restrictions, including a two-month shutdown of cafes and bars in Paris and surrounding areas.

In Spain, the central bank governor this week warned that the accelerating spread of the virus could force the government to impose restrictions that would produce an economic contraction of as much as 12.6 percent this year.

The European Central Bank’s chief economist on Tuesday cautioned that the 19 countries that share the euro currency may not recover from the disaster until 2022, with those that are dependent on tourism especially vulnerable.

Summer increasingly feels like a distant memory.

In August, with infection rates down, lockdowns lifted, and many Europeans indulging in the sacred ritual of the summer holiday, signs of revival were abundant. Many European economies expanded dramatically as people returned to shops, restaurants and vacation destinations.

Hopes had also been buoyed by a landmark agreement forged by the European Union to raise a $750 billion ($883 billion) euro relief

Read the rest